Study of the TRF1 telomeric protein as therapeutic target in Glioblastoma

Información

Fecha: 14/09/2018
Hora 14:00
Lugar: CNIO Auditorium
Conferenciante Leire Bejarano
Procedencia Telomeres and Telomerase Group, Molecular Oncology Programme
Supervised by Maria A. Blasco, Telomeres and Telomerase Group, Molecular Oncology Programme
Entrada libre hasta completar aforo